Physician profile
Adrian A Simien
NPI 1891224507
$1,323.35
in general payments reported to CMS, 2019-2025
13 companies · $58.82 in 2025
The $58.82 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $168 · 2022: $560 · 2023: $142 · 2024: $395 · 2025: $58.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $595.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $509.73 | 2021-2025 | Lo Loestrin Fe, Liletta |
| Medtronic, INC. | $151.44 | 2024 | Truclear |
| Meditrina | $142.59 | 2021-2023 | |
| Myriad Genetic Laboratories, INC. | $121.89 | 2022 | |
| Intuitive Surgical, INC. | $111.57 | 2024 | |
| Organon LLC | $73.53 | 2021-2025 | Nexplanon |
| Acera Surgical, INC. | $67.67 | 2024 | Restrata Wound Matrix |
| Pfizer INC. | $38.15 | 2023 | |
| Mayne Pharma Commercial LLC | $28.93 | 2021 | |
| Hologic Sales and Service, LLC | $28.27 | 2024 | Aptima |
| Exeltis, USA INC. | $19.45 | 2021 | |
| Coopersurgical, INC. | $15.30 | 2024 | Paragard T 380a |
| Shield Therapeutics INC | $14.83 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrian Simien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.